Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 1997

View Archived Issues

Trimidox enhances effects of doxorubicin in vivo

Preliminary clinical results for LMB-2

Update on Interferon Sciences' Alferon N Injection

LeukoSite and collaborators discover monoclonal antibody that blocks HIV infection

Osiris Therapeutics obtains U.S. patent for mesenchymal stem cell gene therapy

Titan receives U.S. patent for drug delivery to the CNS

Panax to acquire CorBec

FDA advisory committee votes against Myotrophin approval

Pfizer and Oncogene characterize EGF receptor TK inhibitor

Cubist and Novalon collaborative research agreement

Orally active FdUrd derivative prepared at Taiho

Prevention of breast cancer with Targretin

Menarini prepares new NNRTIs with potent anti-HIV activity

Preclinical characterization of aplidine

CRF receptor antagonist from Pfizer active in animal model of depression

Preclinical and preliminary clinical studies on flavopiridol

Oral toxicity of SarCNU in rats

Preliminary phase I results for dolastatin 10 in advanced solid tumors

Animal and human pharmacokinetics of 9-NC reported

Dura acquires two intranasal steroid products from Syntex

IL-18 evaluated for biological and antitumor activity

Data from U.K. phase III trial of Zacutex presented

RPR receives FDA clearance for new indication of enoxaparin

Forest submits NDA for antidepressant

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...